Formulation insights, R&D matrix updates, and contract manufacturing services from Olympia Biosciences™ — Europe's evidence-based supplement CDMO.https://olympiabiosciences.com/kohttps://olympiabiosciences.com/ko/rd-hub/bbb-permeable-nanomicelles-cognitive-formulation/https://olympiabiosciences.com/ko/rd-hub/bbb-permeable-nanomicelles-cognitive-formulation/Large, highly lipophilic botanical extracts and cognitive enhancers fail to efficiently cross the blood-brain barrier (BBB) via standard oral delivery.https://olympiabiosciences.com/ko/rd-hub/sustained-release-catecholamine-modulators-cdmo/https://olympiabiosciences.com/ko/rd-hub/sustained-release-catecholamine-modulators-cdmo/Standard dopaminergic precursors cause sharp neurochemical spikes followed by severe crashes, disrupting sustained executive function.https://olympiabiosciences.com/ko/rd-hub/endocrine-metabolic-womens-health-formulation/https://olympiabiosciences.com/ko/rd-hub/endocrine-metabolic-womens-health-formulation/Stabilizing highly sensitive isomeric ratios (e.g., 40:1 Myo-inositol to D-chiro-inositol) alongside liposomal antioxidants in a unified, high-payload matrix to reduce pill burden.https://olympiabiosciences.com/ko/rd-hub/glycolysis-restricted-fsmp-contract-manufacturing/https://olympiabiosciences.com/ko/rd-hub/glycolysis-restricted-fsmp-contract-manufacturing/Masking severe dysgeusia while delivering high-density, zero-carbohydrate lipid calories without thermal degradation during clinical pasteurization.https://olympiabiosciences.com/ko/rd-hub/clinical-grade-liposomal-antioxidants-cdmo/https://olympiabiosciences.com/ko/rd-hub/clinical-grade-liposomal-antioxidants-cdmo/Achieving intravenous-comparable plasma concentrations of critical antioxidants (e.g., Glutathione, Vitamin C) via oral administration due to rapid oxidation.https://olympiabiosciences.com/ko/rd-hub/longevity-senolytics-custom-formulation/https://olympiabiosciences.com/ko/rd-hub/longevity-senolytics-custom-formulation/NAD+ precursors and phytosenolytics (e.g., Fisetin, Spermidine) exhibit extremely poor aqueous solubility, rapid gastric degradation, and low intracellular penetrance.https://olympiabiosciences.com/ko/rd-hub/targeted-postbiotics-gut-brain-cdmo/https://olympiabiosciences.com/ko/rd-hub/targeted-postbiotics-gut-brain-cdmo/Potent short-chain fatty acids (SCFAs) like Butyrate possess a highly offensive odor and degrade before reaching the targeted lower gastrointestinal tract.https://olympiabiosciences.com/ko/rd-hub/neuro-metabolic-cognitive-support-cdmo/https://olympiabiosciences.com/ko/rd-hub/neuro-metabolic-cognitive-support-cdmo/Providing alternative cerebral energy substrates (ketone precursors) without causing extreme gastrointestinal distress typical of high-dose medium-chain triglycerides.https://olympiabiosciences.com/ko/rd-hub/nanomicellar-endothelial-support-cdmo/https://olympiabiosciences.com/ko/rd-hub/nanomicellar-endothelial-support-cdmo/Potent venotonic flavonolignans (e.g., Diosmin, Hesperidin) are massive, highly hydrophobic brick-dust molecules with standard oral bioavailability often below 2%, classified as BCS Class IV.https://olympiabiosciences.com/ko/rd-hub/glp-1-companion-formulation-rd-services/https://olympiabiosciences.com/ko/rd-hub/glp-1-companion-formulation-rd-services/Drastically delayed gastric emptying and gastrointestinal distress associated with GLP-1 agonists require ultra-gentle, high-density nutrient matrices to preserve lean muscle mass.https://olympiabiosciences.com/ko/services/softgel/https://olympiabiosciences.com/ko/services/softgel/유럽 최고 생산 능력을 자랑하는 소프트젤 CDMO: 3개의 독립적인 로터리 다이 캡슐화 라인, 월 1억 개 이상의 캡슐 생산, 젤라틴 및 HPMC 식물성 소프트젤을 취급합니다. 17년간 QA 불만 제로를 기록했습니다. GMP 및 ISO 22000 인증을 받았습니다.https://olympiabiosciences.com/ko/services/for-doctors/https://olympiabiosciences.com/ko/services/for-doctors/Olympia Biosciences™와 함께 의사가 직접 처방한 보충제 브랜드를 런칭하세요. 임상 용량의 맞춤형 EBM 기반 제형, HPLC/GC-MS 배치 검증, 완전한 IP 이전, AI 기반 안전성 검증 스크리닝을 제공합니다. 제로 컨플릭트 — 당사는 고객과 결코 경쟁하지 않습니다.https://olympiabiosciences.com/ko/services/fsmp-medical-food/https://olympiabiosciences.com/ko/services/fsmp-medical-food/EU 위임 규정 2016/128에 따른 전문적인 EU 규제 FSMP 및 의료용 식품 위탁 제조를 제공합니다. 종양학 FSMP, 대사 영양, 수술 후 회복 제형 등이 포함됩니다. 2009년부터 EBM 기반 임상 영양제를 제조해 왔습니다.https://olympiabiosciences.com/ko/services/ip-security/https://olympiabiosciences.com/ko/services/ip-security/ISO/IEC 27001:2023에 따라 정보 보안 감사를 받은 유일한 유럽 CDMO입니다. 철통같은 NDA 프레임워크, 고객에게 완전한 제형 IP 소유권 이전, 소비자 브랜드와의 충돌 제로를 보장합니다. 귀사의 보충제 제형 영업 비밀을 보호하십시오.https://olympiabiosciences.com/ko/services/private-label-vs-cdmo/https://olympiabiosciences.com/ko/services/private-label-vs-cdmo/B2B 분야의 확실한 가이드: 자체 브랜드 보충제와 진정한 CDMO 위탁 제조의 차이점을 설명합니다. IP 소유권, 제형 독점성, 공급업체 자격 요건, 그리고 프리미엄 보충제 브랜드들이 독점 제형을 보호하는 방법을 이해하십시오.https://olympiabiosciences.com/ko/services/scaling/https://olympiabiosciences.com/ko/services/scaling/제약 품질의 PPQ 검증 (Cpk >1.33), HPLC/GC-MS 배치별 CoA, ISO 22000 GMP, 그리고 완전한 공급망 추적성을 갖춘 대량 보충제 위탁 제조를 제공합니다. 7자리 수 생산량의 일관성을 요구하는 프리미엄 브랜드들을 위한 스케일업 CDMO입니다.https://olympiabiosciences.com/ko/services/technology/https://olympiabiosciences.com/ko/services/technology/유럽에서 가장 진보된 보충제 제형 기술: 리포솜 캡슐화, 난용성 화합물을 위한 나노 미셀화, 장용 코팅 DRcaps, 그리고 독점적인 AI 기반 칵테일 효과 제거 기술을 제공합니다. 배치별 HPLC/GC-MS 검증을 완료합니다.